Time for investors to be fearful, not greedy – and sell?
The Covid-19 crash proved a great investment opportunity. Does the vaccine mean it’s time to sell?


“Buy on the sound of cannons, sell on the sound of trumpets.” So runs the old investment adage, apocryphally attributed to a member of the Rothschild banking dynasty. The idea – that you should invest when everyone is panicking and assets are cheap, and sell when everyone is jubilant, and assets are expensive – makes perfect contrarian sense. Investing in March this year, when fear of coronavirus and its impact was at a peak, certainly took a lot of nerve, but the level of panic was unmistakable. Today the question is: as vaccine news sends many markets to new highs, is this the “trumpet” moment?
Not yet, perhaps – but we might be getting close. One sentiment survey that I like to watch – the monthly survey of global fund managers from Michael Hartnett’s team at Bank of America (BoA) – is flashing a few warning signs that big investors might be getting ahead of themselves. The fact that this month’s was the most bullish survey of the year so far isn’t a surprise given the year we’ve had. But significantly, the levels of cash held by fund managers have fallen sharply from 4.4% to 4.1%. That’s below the 4.2% recorded in January, before Covid-19 had gripped the public consciousness anywhere outside of China. More importantly, based on past readings, below 4% is a “sell” signal, notes BoA.
There are still areas that will benefit from the “reopening” trade – there has been a big shift (or “rotation”, as City traders like to describe it) into the sectors which suffered most during the Covid-19 sell-off – emerging markets and small companies have seen particularly large flows of money in the past month, along with banks and value stocks generally. What investments still look neglected? At a market level, the eurozone and Japan are still lagging, while the UK remains widely disliked (a constant in this survey since the 2016 vote for Brexit). But even Britain is less hated than the energy sector.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
In short, if you’re looking for good bets today, stick with value stocks and beneficiaries of re-opening, and be long Japan, the eurozone, the UK and energy. But be ready for a bumpier ride in 2021 when good economic news could spell pain for wider markets.
That brings us to one other point from the survey that’s worth pulling out: despite their belief in a relatively strong recovery, global fund managers are still remarkably complacent about inflation. While most expect prices to rise next year, only 4% anticipate that inflation will be “a lot higher”. Instead, a majority are still backing the conveniently ideal scenario of “above-trend growth and below-trend inflation”. A surprise resurgence of inflation next year is exactly the sort of scenario that could derail markets. So hang on to your gold (and bitcoin).
I wish I knew what carried interest was, but I’m too embarrassed to ask
“Carried interest” or “carry” is a perk enjoyed mainly by private equity executives. In short, it’s a performance fee. The managers typically take a 20% share of the profits of a fund (on top of management fees) with the idea that this aligns their interests more closely with the investors.
Note that the name “carried interest” has nothing to do with the interest you might get paid on your savings. The term originates with trade voyages in the 16th century, where captains of ships sailing from Europe to Asia or America would take a 20% share of the profit.
You might question why a performance fee would make an investment manager try harder to make good investments, but that’s not the most controversial thing about carried interest. The real issue is that it is taxed as a capital gain rather than income, and so incurs a lower tax rate. In the UK for example, the capital gains tax top rate is 28% – it’s 45% for income tax (see page 10).
One argument for taxing capital gains less aggressively than income is to encourage entrepreneurship and investment – the idea being that those who put their own capital at risk to set up or invest in a business should get to retain more of any gains they make by doing so. This makes carried interest contentious, because while there are a few defenders of “carry”, most argue that private equity executives are in effect getting a preferential tax rate on what in any other industry would simply be viewed as a bonus for doing your job, and therefore taxed as income.
Changing the rules on carried interest would not raise much tax. A study by the University of Warwick and the London School of Economics found that taxing “carry” as income in the UK would have raised just £440m in 2017. It might also have unintended consequences in terms of driving the industry elsewhere. However, the argument for fairer tax treatment is politically potent at a time when inequality is never far from the headlines.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
John Stepek is a senior reporter at Bloomberg News and a former editor of MoneyWeek magazine. He graduated from Strathclyde University with a degree in psychology in 1996 and has always been fascinated by the gap between the way the market works in theory and the way it works in practice, and by how our deep-rooted instincts work against our best interests as investors.
He started out in journalism by writing articles about the specific business challenges facing family firms. In 2003, he took a job on the finance desk of Teletext, where he spent two years covering the markets and breaking financial news.
His work has been published in Families in Business, Shares magazine, Spear's Magazine, The Sunday Times, and The Spectator among others. He has also appeared as an expert commentator on BBC Radio 4's Today programme, BBC Radio Scotland, Newsnight, Daily Politics and Bloomberg. His first book, on contrarian investing, The Sceptical Investor, was released in March 2019. You can follow John on Twitter at @john_stepek.
-
HMRC confirms crypto ETN ISA rules
With crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pensioners targeted in fine wine scams – the tactics to watch for
Wine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?